5u28
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==BRD4 first bromodomain (BD1) in complex with dual PI3 kinase inhibitor SF2523== | ==BRD4 first bromodomain (BD1) in complex with dual PI3 kinase inhibitor SF2523== | ||
| - | <StructureSection load='5u28' size='340' side='right' caption='[[5u28]], [[Resolution|resolution]] 1.80Å' scene=''> | + | <StructureSection load='5u28' size='340' side='right'caption='[[5u28]], [[Resolution|resolution]] 1.80Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5u28]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5U28 OCA]. For a <b>guided tour on the structure components</b> use [http:// | + | <table><tr><td colspan='2'>[[5u28]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5U28 OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5U28 FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=82V:3-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-5-(MORPHOLIN-4-YL)-7H-THIENO[3,2-B]PYRAN-7-ONE'>82V</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=SCN:THIOCYANATE+ION'>SCN</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=82V:3-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-5-(MORPHOLIN-4-YL)-7H-THIENO[3,2-B]PYRAN-7-ONE'>82V</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=SCN:THIOCYANATE+ION'>SCN</scene></td></tr> |
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5u2f|5u2f]], [[5u2c|5u2c]], [[5u2e|5u2e]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5u2f|5u2f]], [[5u2c|5u2c]], [[5u2e|5u2e]]</td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http:// | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">BRD4, HUNK1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5u28 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5u28 OCA], [http://pdbe.org/5u28 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5u28 RCSB], [http://www.ebi.ac.uk/pdbsum/5u28 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5u28 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Disease == | == Disease == | ||
| Line 21: | Line 22: | ||
</div> | </div> | ||
<div class="pdbe-citations 5u28" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5u28" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Bromodomain-containing protein 3D structures|Bromodomain-containing protein 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Andrews, F H]] | [[Category: Andrews, F H]] | ||
[[Category: Kutateladze, T G]] | [[Category: Kutateladze, T G]] | ||
Revision as of 12:24, 23 September 2020
BRD4 first bromodomain (BD1) in complex with dual PI3 kinase inhibitor SF2523
| |||||||||||
